Not exact matches
The researchers observed that two
drugs each killed a large fraction of the cells that had begun transitioning:
dasatinib, a
drug that targets the Src Family Kinase (SFK) and RK20449, a new
drug in pre-clinical testing that specifically targets one of the SFK proteins called Hck.
Other
drugs that work in a similar way to
dasatinib are also under investigation by Professor Winder's team.
Researchers at the University of Sheffield investigated a
drug called
dasatinib, which works by blocking certain chemical signals that stimulate the growth of cancer cells.
Because
dasatinib is already cleared for clinical use, researchers hope that progress can be made more quickly towards trialling the
drug in humans as a treatment for DMD.
A
drug called
dasatinib was found to be safe and effective for children with chronic myeloid leukemia, according to a clinical trial published in the Journal of Clinical Oncology.
Several targeted
drugs (e.g., imatinib [Gleevec ®],
dasatinib [Sprycel ®]-RRB- are effective for treating CML because they attack cells with the Philadelphia chromosome, the genetic abnormality that is the hallmark of this type of leukemia.
He has played a key role in the discovery and development of multiple approved
drugs, including imatinib (Gleevec),
dasatinib (Sprycel), and enzalutamide (Xtandi).
A phase I study of
dasatinib in children and adolescents with chronic myeloid leukemia (CML) and other malignancies determined dosing for further studies and suggested the
drug is well tolerated and effective in these patients.